生物标志物 生物标志物
Tahmida Sharmin1,2, Pratishtha Chatterjee1,3, James D Doecke4,5
1Macquarie Medical School, Macquarie University, Macquarie Park, NSW, Australia.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
在具有β-粉样蛋白斑块的认知正常个体中,较高的血总Tau与增加的脊髓菌素有关,这表明早期的阿尔茨海默病途径参与. 这些基米林与粉样β负载相反相关,可能表明有补偿机制.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 脂质代谢 脂质代谢是什么
背景情况:
- 血基米林水平的变化与阿尔茨海默病 (AD) 有关,这表明在病原发生过程中存在脂质代谢中断.
- 血总Tau反映了AD中的神经元损伤和神经退行.
- 通过在症状前研究基米林代谢和陶释放,可以了解阿尔茨海默病的生化途径.
研究的目的:
- 在认知上正常的个体中探索血脊髓水平和总Tau之间的关系.
- 检查在前症状阿尔茨海默氏症中基胺,总Tau和皮质粉样蛋白-β (Aβ) 负载之间的相关性.
- 为了识别潜在的早期生物标志物为AD的发病因子.
主要方法:
- 用针对性质谱分析分析的血样本用于斯芬戈米林和单分子阵列 (Simoa) 总Tau.
- 该研究包括来自KARVIAH队列的100名认知正常 (CN) 个体,按皮质Aβ负载 (CN Aβ-和CN Aβ+) 分类.
- 评估了横截面相关性,控制混变量并应用错误发现率 (FDR) 校正.
主要成果:
- 仅在CN Aβ+个体中发现了基米林和总Tau之间的显著正相关性.
- 这些关联在调整混因素和FDR纠正后仍然强.
- 在CN Aβ+个体中,与总Tau相关的斯芬戈米林与皮质Aβ负荷有显著的反相关性.
结论:
- 血总Tau的升高与患有Aβ斑块的预症状阿尔茨海默氏症患者的高米林相关,将tau释放与米林通路联系起来.
- 较高水平的总Tau相关的米林与较低的皮质Aβ负载相关,可能反映了早期的补偿机制.
- 总-Tau相关的甲基氨酸可以作为潜在的生物标志物,以了解症状前的AD机制.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


